Jazz Pharmaceuticals plc (JAZZ)
Latest JAZZ Insider Trades
Bruce C. Cozadd - DirectorOpen-market sale$1.52M- Bruce C. Cozadd - DirectorOpen-market sale$1.44M
About Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
- DUBLIN
- 2,890
- 2007
- XNAS
https://www.jazzpharmaceuticals.comSEC filings for JAZZ on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 28,456 | $6.82M |
| Grant or award | 11 | 17,655 | |
| Option exercise | 4 | 20,644 |
JAZZ Insider Transactions (Form 4)
3790 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Samantha Pearce - Officer | Tax withholding / forfeiture | Ordinary Shares |
Recent JAZZ Form 8-K Filings
5Recent JAZZ Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ROBERT IANNONE | Officer | 76,921 | $19.21M | View on EDGAR | |
| ORiordan Anne | Director |
JAZZ Insider Trading - FAQ
What is the latest insider trade for JAZZ?
Jazz Pharmaceuticals plc (JAZZ) had 26 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for JAZZ runs to 90 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying JAZZ stock?
No insider purchases of JAZZ were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling JAZZ stock?
7 insider sales of JAZZ were filed in the last 90 days, totaling $6.82M.
Where can I see JAZZ SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks JAZZ Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow JAZZ insider buys?
Create a free InsiderAlpha account and press Watch on this page to add JAZZ to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Samantha Pearce view on EDGAR
- - Rick E. Winningham view on EDGAR
- - Ted W. Love view on EDGAR
- - Laura Hamill view on EDGAR
- - Patrick Kennedy view on EDGAR
- - Mark Douglas Smith view on EDGAR
- - Jennifer E. Cook view on EDGAR
- - Seamus Mulligan view on EDGAR
- - Heather Ann McSharry view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where JAZZ's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track JAZZ insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
